Style | Citing Format |
---|---|
MLA | Hosseini S, et al.. "The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors." Iranian Journal of Breast Diseases, vol. 16, no. 2, 2023, pp. 4-21. |
APA | Hosseini S, Salehi M, Jadidi M, Aghili M (2023). The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors. Iranian Journal of Breast Diseases, 16(2), 4-21. |
Chicago | Hosseini S, Salehi M, Jadidi M, Aghili M. "The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors." Iranian Journal of Breast Diseases 16, no. 2 (2023): 4-21. |
Harvard | Hosseini S et al. (2023) 'The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors', Iranian Journal of Breast Diseases, 16(2), pp. 4-21. |
Vancouver | Hosseini S, Salehi M, Jadidi M, Aghili M. The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors. Iranian Journal of Breast Diseases. 2023;16(2):4-21. |
BibTex | @article{ author = {Hosseini S and Salehi M and Jadidi M and Aghili M}, title = {The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors}, journal = {Iranian Journal of Breast Diseases}, volume = {16}, number = {2}, pages = {4-21}, year = {2023} } |
RIS | TY - JOUR AU - Hosseini S AU - Salehi M AU - Jadidi M AU - Aghili M TI - The Mediating Role of Cognitive Emotion Regulation Explaining the Casual Relationship Between Personality Traits and Fear of Cancer Recurrence in Breast Cancer Survivors JO - Iranian Journal of Breast Diseases VL - 16 IS - 2 SP - 4 EP - 21 PY - 2023 ER - |